CG Oncology, Inc.·4

Nov 26, 4:30 PM ET

Rossi Christina 4

4 · CG Oncology, Inc. · Filed Nov 26, 2025

Insider Transaction Report

Form 4
Period: 2025-11-24
Transactions
  • Award

    Director Stock Option (right to buy)

    2025-11-24+20,88920,889 total
    Exercise: $43.56Exp: 2035-11-23Common Stock (20,889 underlying)
Footnotes (1)
  • [F1]1/36th of the shares subject to the option vest monthly following November 24, 2025, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4